ProfileGDS4718 / 220818_s_at
TitleColorectal cancer: homogenized tumor tissues
OrganismHomo sapiens


no metastasis metastatic recurrence metastasis stage: 0 stage: 1 stage: 2a stage: 2b stage: 3b stage: 3c stage: 2a stage: 2b stage: 3b stage: 3c stage: 4 GSM549121 GSM549102 GSM549104 GSM549108 GSM549119 GSM549133 GSM549139 GSM549099 GSM549109 GSM549110 GSM549114 GSM549122 GSM549134 GSM549136 GSM549140 GSM549111 GSM549113 GSM549132 GSM549137 GSM549142 GSM549100 GSM549107 GSM549115 GSM549116 GSM549120 GSM549131 GSM549118 GSM549129 GSM549123 GSM549124 GSM549126 GSM549128 GSM549103 GSM549117 GSM549138 GSM549141 GSM549130 GSM549101 GSM549105 GSM549106 GSM549112 GSM549125 GSM549127 GSM549135 24% 27% 39% 31% 25% 20% 23% 31% 30% 16% 21% 29% 32% 26% 29% 26% 28% 28% 25% 31% 31% 21% 26% 34% 22% 30% 26% 18% 23% 25% 26% 29% 31% 33% 31% 33% 29% 31% 24% 51% 26% 26% 33% 25% sort by disease state sort by other Gene Expression Profile
Graph caption help
SampleTitleValueRank
GSM549121patient 080, normal, homogenized [OPG study]4.2895324
GSM549102patient 115, normal, homogenized [OPG study]4.4454327
GSM549104patient 119, normal, homogenized [OPG study]4.9330139
GSM549108patient 138, normal, homogenized [OPG study]4.6416531
GSM549119patient 077, normal, homogenized [OPG study]4.3513925
GSM549133patient 032, cancer, homogenized [OPG study]4.1102120
GSM549139patient 042, cancer, homogenized [OPG study]4.2538923
GSM549099patient 107, normal, homogenized [OPG study]4.5906431
GSM549109patient 139, normal, homogenized [OPG study]4.5535230
GSM549110patient 046, normal, homogenized [OPG study]4.0076616
GSM549114patient 063, normal, homogenized [OPG study]4.1462821
GSM549122patient 082, normal, homogenized [OPG study]4.5031729
GSM549134patient 033, cancer, homogenized [OPG study]4.601232
GSM549136patient 036, cancer, homogenized [OPG study]4.3285726
GSM549140patient 044, cancer, homogenized [OPG study]4.455129
GSM549111patient 047, normal, homogenized [OPG study]4.3545926
GSM549113patient 057, normal, homogenized [OPG study]4.4155228
GSM549132patient 031, cancer, homogenized [OPG study]4.4572228
GSM549137patient 038, cancer, homogenized [OPG study]4.3308825
GSM549142patient 047, cancer, homogenized [OPG study]4.7051531
GSM549100patient 110, normal, homogenized [OPG study]4.6099731
GSM549107patient 135, normal, homogenized [OPG study]4.1575321
GSM549115patient 068, normal, homogenized [OPG study]4.3383526
GSM549116patient 072, normal, homogenized [OPG study]4.7078834
GSM549120patient 078, normal, homogenized [OPG study]4.2202422
GSM549131patient 030, cancer, homogenized [OPG study]4.4714330
GSM549118patient 074, normal, homogenized [OPG study]4.3752626
GSM549129patient 027, cancer, homogenized [OPG study]4.1001818
GSM549123patient 088, normal, homogenized [OPG study]4.2387423
GSM549124patient 006, cancer, homogenized [OPG study]4.3731525
GSM549126patient 015, cancer, homogenized [OPG study]4.3832626
GSM549128patient 025, cancer, homogenized [OPG study]4.4853629
GSM549103patient 117, normal, homogenized [OPG study]4.6203231
GSM549117patient 073, normal, homogenized [OPG study]4.6412233
GSM549138patient 041, cancer, homogenized [OPG study]4.5621431
GSM549141patient 045, cancer, homogenized [OPG study]4.5872433
GSM549130patient 028, cancer, homogenized [OPG study]4.5263329
GSM549101patient 111, normal, homogenized [OPG study]4.6139531
GSM549105patient 128, normal, homogenized [OPG study]4.3154524
GSM549106patient 134, normal, homogenized [OPG study]5.5381351
GSM549112patient 048, normal, homogenized [OPG study]4.3619226
GSM549125patient 011, cancer, homogenized [OPG study]4.3927826
GSM549127patient 024, cancer, homogenized [OPG study]4.6730933
GSM549135patient 035, cancer, homogenized [OPG study]4.2683725